In neuropathology, LAMP2 concentration has been reported to be decreased in the patient’s cerebrospinal fluid (CSF) of Parkinson’s disease [34,35] and increased in patients with Alzheimer’s [36,37]. Here, LAMP2 is linked to Parkinson disease.